Number of Shares
24.42 Mil
Current Holdings Value*
$471.16 Mil
% of Portfolio
5.27%
Total Estimate Gain
$524.39 Mil
% of Total Estimate Gain
332.73%

BAKER BROS. ADVISORS LP's Summit Therapeutics Inc Holding Summary

As of 2025-03-31, BAKER BROS. ADVISORS LP held 24.42 Mil shares of Summit Therapeutics Inc(SMMT), totaling $471.16 Mil. This investment constitutes 5.27% of their stock portfolio, and BAKER BROS. ADVISORS LP now holds 3.29% of the outstanding Summit Therapeutics Inc(SMMT) stock.

The initial trade took place in 2022Q4. And since then BAKER BROS. ADVISORS LP has made 4 purchases of SMMT, at an average price of $5.13, for a total of 30.73 Mil shares. In addition, there have been 2 sales at an average price of $1.98 for 6.30 Mil shares. Based on historical transaction data and SMMT's current price of $27.41, BAKER BROS. ADVISORS LP's estimated gain on his SMMT holdings is $524.39 Mil, reflecting a 332.73% gain to date.

BAKER BROS. ADVISORS LP SMMT ($27.41) Holding Chart

BAKER BROS. ADVISORS LP SMMT ($27.41) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1